Analona Therapeutics is leveraging cutting-edge research from a world-leading pancreatic cancer research group in the UK to develop groundbreaking antibody-based therapies that exploit metabolic cancer cell vulnerabilities.
Company Details
- Founded
- 2024
- Address
- Ole Maaløes Vej, Copenhagen,capital Region Of Denmark 2200,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Copenhagen, Capital Region of Denmark
Analona Therapeutics Questions
Analona Therapeutics's LinkedIn profile is https://dk.linkedin.com/company/analonatherapeutics
Analona Therapeutics's industry is
Biotechnology Research
Analona Therapeutics's top competitors are
Prenaital,
Mycoverse,
Troya Therapeutics,
Arcanabio,
Sulis Therapeutics,
Glioray,
Darerl Aps,
Ovartix,
Nordicblue Aps,
Phanofi.
Analona Therapeutics's categories are Biotechnology Research
Analona Therapeutics's founding year is 2024
